Yuanmei Zhu Selected Research

Vaccines

12/2022	SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron.
12/2021	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.
9/2017	Identification of a novel HIV-1-neutralizing antibody from a CRF07_BC-infected Chinese donor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanmei Zhu Research Topics

Disease

13	Infections 01/2023 - 01/2017
6	COVID-19 01/2023 - 01/2020
5	Virus Diseases (Viral Diseases) 01/2020 - 01/2017
2	HIV Infections (HIV Infection) 01/2021 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2020 - 11/2019
1	Drug-Related Side Effects and Adverse Reactions 11/2019

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2017
8	Peptides (Polypeptides)IBA 12/2022 - 01/2017
7	LipopeptidesIBA 01/2023 - 01/2017
7	Enfuvirtide (Fuzeon)FDA Link 01/2020 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2020
3	VaccinesIBA 12/2022 - 09/2017
2	CholesterolIBA 01/2023 - 12/2021
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 12/2022 - 01/2021
2	Anti-HIV Agents (AIDS Drugs)IBA 01/2020 - 01/2019
1	LipidsIBA 01/2023
1	SARS-CoV-2 spike proteinIBA 11/2020
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2020
1	Peptide Hydrolases (Proteases)FDA Link 10/2017
1	EpitopesIBA 09/2017
1	Monoclonal AntibodiesIBA 09/2017

Therapy/Procedure

6	Therapeutics 12/2021 - 01/2017
1	Microspheres (Microsphere) 11/2020